Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2020

01-01-2020 | Care | Capsule Commentary

Capsule Commentary on Stryczek et. al., De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers’ Perspectives

Author: Isomi M. Miake-Lye, PhD

Published in: Journal of General Internal Medicine | Issue 1/2020

Login to get access

Excerpt

As part of an ongoing quality improvement initiative aiming to discontinue inappropriate prescribing of inhaled corticosteroids among patients with mild-to-moderate chronic obstructive pulmonary disease (COPD), Stryczek and colleagues used a sequential mixed methods approach to explore primary care provider perspectives on inhaled corticosteroid prescribing patterns in patients with low-to-moderate COPD.1 They found that primary care providers’ broad scope of practice made it challenging to keep current with evidence and recommendations. Other key factors in primary care providers’ decision-making included a reluctance to discontinue inherited prescriptions and a deference to the expertise of pulmonologists. …
Literature
1.
2.
3.
4.
Phan K, Brown SR. Decreased continuity in a residency clinic: a consequence of open access scheduling. Fam Med. 2009;41(1):46–50.PubMed
5.
Salisbury C, Montgomery AA, Simons L, Sampson F, Edwards S, Baxter H, Goodall S, Smith H, Lattimer V, Pickin DM. Impact of advanced access on access, workload, and continuity: controlled before-and-after and simulated-patient study, Br J Gen Pract. 2007;57(541):608–614.PubMedPubMedCentral
Metadata
Title
Capsule Commentary on Stryczek et. al., De-implementing Inhaled Corticosteroids to Improve Care and Safety in COPD Treatment: Primary Care Providers’ Perspectives
Author
Isomi M. Miake-Lye, PhD
Publication date
01-01-2020
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05395-8

Other articles of this Issue 1/2020

Journal of General Internal Medicine 1/2020 Go to the issue

Original Research

Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study

Concise Research Report

The Effect of Exposure to Disaster on Cancer Survival

Original Research

Military Sexual Trauma in Older Women Veterans: Prevalence and Comorbidities

Capsule Commentary

Capsule Commentary on Ogunbayo et al., “Treatment Bias in Management of HIV Patients Admitted for Acute Myocardial Infarction: Does it Still Exist?”

Original Research

Hypertension Self-management in Socially Disadvantaged African Americans: the Achieving Blood Pressure Control Together (ACT) Randomized Comparative Effectiveness Trial

Original Reserch

Telemonitoring and Team-Based Management of Glycemic Control on People with Type 2 Diabetes: a Cluster-Randomized Controlled Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits